Mostrar el registro sencillo del ítem
Pharmacological aspects of neuro-immune interactions
dc.contributor.author | Tarasov V.V. | |
dc.contributor.author | Kudryashov N.V. | |
dc.contributor.author | Chubarev V.N. | |
dc.contributor.author | Kalinina T.S. | |
dc.contributor.author | Barreto G.E. | |
dc.contributor.author | Ashraf G.M. | |
dc.contributor.author | Aliev G. | |
dc.date.accessioned | 2020-09-02T22:29:14Z | |
dc.date.available | 2020-09-02T22:29:14Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.2174/1381612823666170829135115 | |
dc.identifier.citation | 24, 1, 15-21 | |
dc.identifier.issn | 13816128 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/6378 | |
dc.description | The use of systematic approach for the analysis of mechanism of action of drugs at different levels of biological organization of organisms is an important task in experimental and clinical pharmacology for drug designing and increasing the efficacy and safety of drugs. The analysis of published data on pharmacological effects of psychotropic drugs possessing immunomodulatory and/or antiviral properties have shown a correlation between central effects of examined drugs associated with the impact on the processes of neurogenesis of adult brain and survival of neurons, and their ability to alter levels of key proinflammatory cytokines. The changes that occur as a result of the influence of pharmacological agents at one of the systems should inevitably lead to the functional reorganization at another. Integrative mechanisms underlying the neuro-immune interactions may explain the "pleiotropic" pharmacological effects of some antiviral and immunomodulatory drugs. Amantadine, which was originally considered as an antiviral agent, was approved as anti-parkinsonic drug after its wide medical use. The prolonged administration of interferon alpha caused depression in 30-45% of patients, thus limiting its clinical use. The antiviral drug “Oseltamivir” may provoke the development of central side effects, including abnormal behavior, delirium, impaired perception and suicides. Anti-herpethetical drug “Panavir” shows pronounced neuroprotective properties. The purpose of this review is to analyze the experimental and clinical data related to central effects of drugs with antiviral or/and immunotropic activity, and to discover the relationship of these effects with changes in reactivity of immune system and proinflammatory response. © 2018 Bentham Science Publishers. | |
dc.language.iso | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Amantadine | |
dc.subject | Amitriptyline | |
dc.subject | Interferon | |
dc.subject | Neuro-immune interaction | |
dc.subject | Neurogenesis | |
dc.subject | Oseltamivir | |
dc.subject | Panavir | |
dc.subject | Semax | |
dc.subject | alpha interferon | |
dc.subject | amantadine | |
dc.subject | amitriptyline | |
dc.subject | antivirus agent | |
dc.subject | cytokine | |
dc.subject | immunomodulating agent | |
dc.subject | oseltamivir | |
dc.subject | panavir | |
dc.subject | peptide derivative | |
dc.subject | psychotropic agent | |
dc.subject | semax | |
dc.subject | unclassified drug | |
dc.subject | oseltamivir | |
dc.subject | probucol | |
dc.subject | antiviral activity | |
dc.subject | behavior disorder | |
dc.subject | brain nerve cell | |
dc.subject | cell survival | |
dc.subject | clinical pharmacology | |
dc.subject | delirium | |
dc.subject | depression | |
dc.subject | drug activity | |
dc.subject | drug analysis | |
dc.subject | drug approval | |
dc.subject | drug design | |
dc.subject | drug efficacy | |
dc.subject | drug indication | |
dc.subject | drug mechanism | |
dc.subject | drug safety | |
dc.subject | human | |
dc.subject | immune system | |
dc.subject | immunomodulation | |
dc.subject | inflammation | |
dc.subject | nervous system development | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | Parkinson disease | |
dc.subject | perception disorder | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | side effect | |
dc.subject | suicide | |
dc.subject | animal | |
dc.subject | drug effect | |
dc.subject | immunology | |
dc.subject | immunomodulation | |
dc.subject | nervous system | |
dc.subject | Animals | |
dc.subject | Antiviral Agents | |
dc.subject | Humans | |
dc.subject | Immune System | |
dc.subject | Immunomodulation | |
dc.subject | Nervous System | |
dc.subject | Oseltamivir | |
dc.subject | Probucol | |
dc.title | Pharmacological aspects of neuro-immune interactions | |
dc.type | Review |